
Opinion|Videos|December 23, 2024
Advancing IgA Nephropathy Care: Emerging Therapies, Unmet Needs, and Economic Considerations
Advertisement
Episodes in this series

Now Playing
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies
2
Digital, Blood-Based Innovations Transform Alzheimer Disease Detection: Ken Cohen, MD, FACP
3
Tirzepatide Plus Hormone Therapy Boosts Weight Loss in Menopause: Regina Castaneda, MD
4
FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause
5















































